Domestic:+91 8550986868sales@anantlabs.com
LoginSign up
/
Anant Labs

Linagliptin

CAS 668270-12-0

Linagliptin
In Stock

Linagliptin

Cat. No. ANT-LNG-00CAS 668270-12-0In Stock
Technical Data
Cat. No.ANT-LNG-00
CAS668270-12-0
Mol. FormulaC25H28N8O2
Mol. Weight472.55 g/mol
IUPAC8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione
SMILESCC#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C
InChIInChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1
InChI KeyLTXREWYXXSTFRX-QGZVFWFLSA-N
PurityNA
Description

Overview

Linagliptin, sold under the brand name Tradjenta among others, is a medication used to treat diabetes mellitus type 2. It is generally less preferred than metformin and sulfonylureas as an initial treatment. It is used together with exercise and diet. It is not recommended in type 1 diabetes. It is taken by mouth

Anant Labs manufacture and furnish high quality Linagliptin impurities for global markets. Our Linagliptin EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dioneLinagliptin668270-12-0TradjentaBI-1356BI 1356TrazentaTrajentaBI-1356-BSlinagliptine

Looking for a specific reference standard?

Tell us what you need. Our team responds within one business day.